An employer may hear that the Department of Labor’s new fee-disclosure rule is “only about pharmacy benefit managers.” For a SIMERP provider, wellness administrator, or broker, stopping there could miss the more relevant part of the story.

DOL’s November 2, 2026 final rule establishes detailed requirements for specified pharmacy benefit management arrangements. Its preamble also addresses broader compensation-disclosure obligations that Congress expanded in February. Those statutory obligations can reach providers outside the PBM-specific regulation. Final rule, preamble Sections D.1 and D.4.

The useful question is not whether a business calls itself a SIMERP company. It is which requirements apply to the plan, services, contractual relationships, and compensation actually involved.

Being outside the PBM-specific rule does not, by itself, put a provider outside ERISA’s compensation-disclosure requirements.

What actually changed

First, Congress changed the statute. Section 6702(c) of the Consolidated Appropriations Act, 2026 broadened the covered-service-provider language in ERISA Section 408(b)(2)(B). “Brokerage services” became “Services (including brokerage services),” while the consulting formulation became “Other services,” including specified functions and related consulting. Public Law 119-75, Division J, §6702(c).

Wellness services, wellness design and management, and third-party administration were not entirely new subjects in the law. They appeared in the earlier brokerage-and-consulting framework. The important 2026 change is the broader description of the providers and services covered. Compare the 2024 statutory text with the amended statute, §1108(b)(2)(B)(ii).

Second, DOL finalized a narrower operational rule. The regulation, 29 CFR §2550.408b-22, addresses PBM services and certain PBM-affiliated advice, recommendations, and referrals for specified large, self-insured ERISA group health plans. It adds detailed compensation information, ongoing reports, and audit access. It is not a universal reporting template for every wellness business. Final rule, paragraphs (b)–(e), (g), and (j).

The dates that matter

February 3, 2026: The statutory amendments became effective upon enactment. DOL expressly states that the expanded provider population must address the statute to rely on its exemption. This is an existing obligation, not a new November starting date. Final-rule preamble, Sections D.1.1 and D.4.

November 2, 2026: The PBM final rule was published as Federal Register Document 2026-22306, at 91 FR 69092–69196. Its legal effective date is January 4, 2027. Its requirements apply for plan years beginning on or after July 1, 2027. Final rule, Dates and paragraph (p).

Applying that plan-year language, a calendar-year plan’s first applicable plan year begins January 1, 2028. That example does not postpone the plan’s separate statutory duties until 2028. Effective dates, applicability dates, and existing obligations answer different questions.

Start with the plan, then the provider’s role

Begin by establishing whether the arrangement is an ERISA-covered group health plan. Section 105 or Section 125 terminology does not resolve that question. ERISA has coverage exclusions, including governmental plans and qualifying church plans. The broader disclosure statute is not limited to the large, self-insured plans addressed by the PBM rule. ERISA coverage, 29 U.S.C. §1003; §1108(b)(2)(B).

Next, identify the actual services. Wellness services, medical management, plan design, compliance services, and third-party administration appear in the amended statutory categories. A broker’s or consultant’s duties turn on its actual arrangement, not just its title. An unrelated accounting or payroll assignment should not automatically be classified as a covered plan service. Statutory service categories, §1108(b)(2)(B)(ii).

The statutory definition generally requires a provider contracting with a covered plan to reasonably expect at least $1,000 in direct or indirect compensation connected with the listed services under the arrangement, including relevant affiliate or subcontractor activity. That is not $1,000 per employee. Apply the statutory compensation definitions and contractual scope rather than borrowing a measurement period from a different requirement. Provider and compensation definitions.

The PBM regulation requires a separate scope check. Its large-employer test generally looks to average employment in the preceding calendar year; its specified-large-plan test concerns certain employee-organization or joint-sponsor plans and counts participants. The counting and aggregation rules matter. “100 covered lives” is not a reliable substitute. Final rule, paragraphs (b) and (m).

Where SIMERP and wellness arrangements fit

DOL’s preamble expressly discusses non-PBM third-party administrators. Its medical-management TPA example identifies potential disclosures involving administrative and per-employee-per-month fees, provider and network compensation, affiliate and subcontractor compensation, and other revenue streams. This is agency interpretation of the broader statute, not a separate final TPA regulation. Preamble Section E.1.3.1, pages 69109–69110.

For a SIMERP arrangement, review the service agreement and compensation trail rather than the proposal’s label. Who administers reimbursements? Who supplies wellness or medical services? Who receives a commission or referral payment? Which organization contracts with the plan, and which performs the work? These are recommended diligence questions, not findings that every participant has an identical disclosure obligation.

A subcontractor or affiliate is not independently a covered service provider solely because it performs work for another provider. Its compensation may still matter to the contracting provider’s disclosure. Specified transaction-based payments, including commissions and finder’s fees, receive separate statutory attention. §1108(b)(2)(B)(ii)(III) and (iii)(V).

Similarly, a TPA that bundles actual PBM services through a subcontractor needs a closer PBM-rule analysis. Conversely, an independent broker is not a PBM-affiliated consultant merely because its benefits package includes pharmacy access. Final-rule preamble, Sections E.1.3–E.1.5.

Employer-paid invoices also deserve careful classification. The statute distinguishes plan payments, sponsor payments, and indirect compensation; the PBM regulation expressly addresses sponsor payments made on a plan’s behalf. Do not assume that every employer-paid wellness fee is automatically covered, or automatically exempt, without reviewing the arrangement. Statutory definitions; PBM rule, paragraph (e)(2).

What disclosure actually requires

Under the broader statute, covered providers disclose in writing to the responsible plan fiduciary: the person with authority to cause the plan to enter, extend, or renew the arrangement. Core subjects include services, applicable fiduciary status, direct and indirect compensation, relevant payers and payment arrangements, specified interentity payments, termination compensation, and how payment will be received. §1108(b)(2)(B)(iii)–(iv).

This is not a requirement to post every commission agreement publicly. The law identifies the recipient and information. It permits appropriate formulas, per-enrollee charges, and qualifying estimates that provide enough information to evaluate reasonableness. §1108(b)(2)(B)(ii)(II).

Initial disclosures are due reasonably in advance of entering, extending, or renewing the arrangement. Changes generally must be disclosed as soon as practicable and within 60 days of learning of them, subject to the statutory exception. A separate good-faith error provision generally requires correction within 30 days of discovery. §1108(b)(2)(B)(v)–(vii).

For arrangements covered by the PBM rule, additional requirements address rebates, spread compensation, pharmacy recoupments, formulary incentives, pricing, ongoing reports, and audit access. Ninety days before renewal or extension is deemed reasonable; it is not a universal 90-day rule for every initial contract. Reports are generally semiannual, or quarterly at the plan’s request. Annual audit access on request is not a command that every employer conduct an annual audit. Final rule, paragraphs (e), (g), and (j).

Good-faith enforcement relief is not a disclosure holiday

DOL’s temporary enforcement policy extends beyond PBMs to the broader statutory population of covered providers and responsible fiduciaries. It runs from February 3, 2026 to the rule’s plan-year-based applicability point. Preamble Section D.4, page 69105.

For providers, the policy depends on making disclosures using a good-faith interpretation of the amended law. For fiduciaries, it depends on a good-faith interpretation of their obligations when evaluating the arrangement’s reasonableness. It is enforcement discretion, not a statutory exemption, blanket postponement, or assurance against private claims. DOL’s stated policy and conditions.

SIMERPU’s practical reading is straightforward: document a reasoned implementation process now. Do not turn “good faith” into a script saying that disclosures can wait.

What this development does not establish

These authorities concern service arrangements, compensation disclosure, and fiduciary review. They do not determine whether a particular SIMERP reimbursement is tax-free, validate Section 125 elections, or approve projected FICA savings. They do not establish state administrator licensing or producer authorization. Scope of §1108(b)(2); final rule, paragraph (a).

Keep those review tracks separate. A disclosure is not federal tax approval; a producer license is not evidence of administrator authorization. This article does not identify a statutory ban on all benefits discussions. A recommended pause in program-specific outreach while required authorization is checked remains a precaution, not a newly invented blanket prohibition.

SIMERPU’s assessment

The most useful response is neither “this applies to everyone” nor “this has nothing to do with us.” It is a documented review of the plan, services, payment sources, and responsible parties.

We recommend adding a compensation-disclosure checkpoint to provider evaluations and renewals. The review should establish the applicable framework, what information the employer receives, who evaluates it, and how missing or changing information is handled. That is SIMERPU’s recommended practice, not a claim that one new federal checklist fits every arrangement.

Receiving a disclosure is not the same as establishing reasonable compensation or completing fiduciary review. The underlying exemption still requires necessary services, a reasonable arrangement, and no more than reasonable compensation. §1108(b)(2)(A)–(B).

Transparency should make an employer’s decision easier to understand, not replace the work needed to support it.

Mardy Gould’s take

I see this as an opportunity for our industry to get better at explaining what we do, who is responsible, and how the employer’s money moves.

Compensation should not be an uncomfortable subject. Providers, administrators, and brokers perform valuable work. The goal is to explain that work and its cost clearly enough for an employer to make an informed decision.

What I do not want is another headline turned into a sales tactic. Telling every SIMERP business that a PBM rule automatically applies is not education. Neither is dismissing the entire development because your company does not call itself a pharmacy benefit manager.

Our responsibility is to ask better questions, understand the actual arrangement, and bring the right advisers into the discussion when an answer needs more work. An employer should not have to piece together responsibilities from a presentation, an invoice, and several different explanations.

For me, the positive takeaway is simple: clear documentation and understandable compensation build trust. That is a standard worth strengthening, regardless of which particular disclosure provision applies.

What to ask. What to request. Who should review it.

Ask: Which disclosure framework applies to this plan and service agreement? Who receives direct or indirect compensation, including relevant commissions and affiliate payments? Who is the responsible fiduciary, and which contract and plan-year dates control?

Request: The plan documents, service agreement, written compensation disclosure, fee and commission schedules relevant to the review, organizational relationships, and a dated record of questions and responses. Compare those records with the proposal rather than assuming they describe the same arrangement.

Review: The responsible fiduciary should evaluate the information with appropriate benefits counsel or other qualified advisers. An incomplete disclosure calls for a documented response and review of the applicable correction and relief provisions, not an automatic instruction to continue or terminate the relationship. Statutory fiduciary-relief conditions, §1108(b)(2)(B)(viii).

For a broader document-review framework, read Can Your SIMERP Provider Answer These Compliance Questions?. For the separate tax analysis of employee payments, see Can One Annual Wellness Activity Support Monthly SIMERP Payments?. These are separate questions, and keeping them separate makes the conversation more useful.